INS and fatty liver disease: Samuel and Shulman’s foundational work illustrates how hepatic steatosis impairs insulin signaling pathways (28) by potentially decoupling peripheral glucose and lipid metabolism, which are components captured by the TyG index, from their downstream vascular consequences (29, 30).